The drug maker Bristol-Myers Squibb reported the results of the clinical trial of the anti-diabetic drug dapagliflozin in a meeting today. Bristol-Myers Squibb, in partnership with AstraZeneca PLC, conducted a clinical study on dapagliflozin for the treatment of the symptoms of diabetes. Researchers reported the results of the one-year study on the diabetes drug in [...]


Posted in
Tags:
